Comparison of first- and second-wave DAAs for HCV GT1: Efficacy, safety, tolerability, and regimen complexity

Blaire E. Burman, Paul Y. Kwo, Kris V. Kowdley

Research output: Contribution to journalReview article

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)352-364
Number of pages13
JournalHepatology International
Issue number3
StatePublished - Jul 2014


  • Direct-acting antivirals
  • Hepatitis C

ASJC Scopus subject areas

  • Hepatology

Cite this